Bell Calvin MD entered the industry of Commercial Research Laboratory in 2008 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6211110, which describes it as a Commercial Research Laboratory. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Research Laboratory. The business provides service to the B2B market.
To acquire more information, please contact Calvin Bell by calling (217) 788-3050 during business hours. You can also write to the business’ Single Location at 800 North Rutledge St, Springfield, Illinois IL 62781. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Bell Calvin MD |
Representative: | Calvin Bell |
Place of Business: | 800 North Rutledge St, Springfield, IL 62781 |
Contact Number: | (217) 788-3050 |
Type of Service: | Commercial Research Laboratory |
SIC Number: | 8731 |
NAICS Number: | 6211110 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2008 |
Income/Year: | $500.000 to $999.999 |
Laborers: | 1 to 4 |
Share This Company: |
Bell Calvin MD is a company operating from Sangamon, Illinois providing professional Commercial Research Laboratory and relevant B2B variables. It was founded in 2008 and registered with the SIC code 8731 as Commercial Research Laboratory, and with the NAICS code 6211110 as Commercial Research Laboratory.
With a current employee count of 1 to 4, Bell Calvin MD has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Calvin Bell at (217) 788-3050 for related queries, or to locate its Single Location using the coordinates 39.81083,-89.65575.
The Single Location can also be found at the street address 800 North Rutledge St in Springfield, Illinois 62781 and can be engaged online through the company website at , the company Twitter , and Facebook page .